Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

FSD Pharma Inc > Ignore the haters
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(495)
•••
Comment by Mil_Man54on Sep 29, 2021 7:14pm
48 Views
Post# 33941431

RE:RE:RE:RE:RE:RE:RE:RE:RE:Ignore the haters

RE:RE:RE:RE:RE:RE:RE:RE:RE:Ignore the hatersStill WRONG....reposting your response doesn't change that.......

DavidRosenberg wrote:
Mil_Man54 wrote: There is no relationship between ELYM and FSD.....you really need to stop making that irrelevant and misleading comparison........data from the ELYM study WILL NOT impact anything FSD has to offer.....

DavidRosenberg wrote:
Mil_Man54 wrote: See there's the problem......FSD HAS NO DATA....JUST HYPE......but you are treating this board as if they are competing with the big boys and the data is forthcoming.......IT IS NOT.....nothing is coming anytime soon.......

DavidRosenberg wrote:
Mil_Man54 wrote: Rosenberg constantly deflects.....and ignores the history of FSD to include the incompetence and complicense of the BoD which includes AD that equally contributed to the failures of FSD....but Rosenberg is adament to put the full blame on Raza Bokari and the only blame to be had by anyone else is that they made a mistake in hiring him.......that is complete BS mean't to absolve AD of any accountabilty........he has prsented ZERO hard data to support anything he says.....and FYI...hard data from successful companies does not represent FSD or translate to its success......I challenge you to produce one item of data to support your assertions about FSD.....and telling us how much cash they have is NOT relevant.......money in a bankl account DOES NOT translate to success.....and an aging building that's been on the market for a few years now does not count as a viable asset....it is a never ending expense and liability.....and I want my money back as much as anyone...but I refuse to lower myself to your tactics of pumping and misleading investors......

DavidRosenberg wrote:
Mil_Man54 wrote: WRONG.....focus on the whole picture.....not intentions going forward.......Rosenberg will always deflect when it comes to FSD's past failures........


DavidRosenberg wrote:

Focus on what the company is doing and wants to do

cheers


 


 

 

i won't deflect , raza made a mess of things since 2019 , AD and the board choose raza but now there is a huge reset happening 

Only hard data and results will ultimately decide 

I want FSD stock to go up who doesn't 


 


 

 


lucid psychecuticals has an important role in making fsd Pharma known around the o bestie community for psychedelic clinical trials 

it psychedelic industry starts entering a bull market and analysts recognize FSD Pharma data then we could see movement and stop fighting and bashing each other ??


https://www.bloomberg.com/news/articles/2021-09-27/drug-startup-raises-70-million-for-psychedelics-without-a-trip?utm_campaign=socialflow-organic&utm_medium=social&utm_content=business&cmpid=socialflow-facebook-business&utm_source=facebook&fbclid=IwAR1MMam6f0K9dRslDpZb6BvPwrwVJ-oEzlFSiSqlyXTMfiH8HEn8RnOFJEU


 


data from ELYM could impact FSD201 molecule since both companies have PEA maybe it's smarter to see ELYM complete their trial first before exploring other options ?
 

 



I disagree although speculative , data from $ELYM could impact FSD postively
or negatively based on their results 
 


 


 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities